Home

Richard E. Lowenthal, President and CEO: ARS Pharmaceuticals SPRY Planned sale · Filed 25/08/21

Trade details

Type
Planned sale notice
Planned sale date
25/08/21
Filed
25/08/21

More to sell after $703.8K in 3 months

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/07/22~25/09/20

Richard E. Lowenthal's recent trades

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $177K

    Filed 09/11

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $421.1K

    Filed 09/04

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $115.6K

    Filed 09/03

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $5,000

    Filed 09/02

  • Richard E. Lowenthal

    Planned saleARS Pharmaceuticals

    $148.2K

    Filed 08/20

Richard E. Lowenthal, CEO — plans to sell 150,000 sh of ARS Pharmaceuticals SPRY · $2.1M · around 08/21 · 10b5-1 plan | Whalegun